Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Are the big M&A players in biopharma waiting out the bear market?
Fierce Biotech
Tue, 02/9/16 - 02:15 pm
Tags:
M&A, Roche, Eli Lilly, Gilead Sciences, Sanofi, Biogen
Elanco’s 4Q15 Performance: Eli Lilly’s Animal Health Segment
Yahoo/Market Realist
Mon, 02/8/16 - 09:46 pm
Tags:
Eli Lilly, animal health, Elanco
Pfizer keeps pushing on early hit Ibrance as Novartis, Lilly rivals near market
Fierce Pharma Marketing
Mon, 02/8/16 - 12:48 pm
Tags:
Pfizer, Ibrance, breast cancer, Novartis, Eli Lilly
Eli Lilly and Co.’s 4Q15 Business Segment Performance
Yahoo/Market Realist
Sat, 02/6/16 - 12:28 pm
Tags:
Eli Lilly, earnings
Elanco Contributed ~15% of Total Revenues for Eli Lilly
Yahoo/Market Realist
Mon, 02/1/16 - 11:22 am
Tags:
Eli Lilly, Elanco, earnings
Forget Biosimilars: It's This Threat That Could Dent AbbVie's Top Line
Motley Fool
Sun, 01/31/16 - 01:37 pm
Tags:
AbbVie, biosimilars, Humira, baricitinib, rheumatoid arthritis, Incyte, Eli Lilly
Eli Lilly's diabetes drugs drive sales
Medical Marketing and Media
Sat, 01/30/16 - 10:40 am
Tags:
Eli Lilly, diabetes, earnings
Eli Lilly and Co Reports Weak Outlook Despite Healthy 4Q Earnings
Bidness, ETC
Thu, 01/28/16 - 08:37 am
Tags:
Eli Lilly, earnings
Lilly, BI step closer to a new heart-risk marketing push on Jardiance
Fierce Pharma Marketing
Wed, 01/27/16 - 04:12 pm
Tags:
Eli Lilly, Boehringer Ingelheim, diabetes, Jardiance, SGLT2 inhibitor
Lilly and Roche Diagnostics to Collaborate on Alzheimer's Disease Adjunct Diagnostic Tool
Yahoo
Wed, 01/27/16 - 10:56 am
Tags:
Eli Lilly, Roche, diagnostics, Alzheimer's disease
Marketing challenges remain in crowded metabolic market
Medical Marketing and Media
Tue, 01/26/16 - 09:16 pm
Tags:
diabetes, Eli Lilly, Sanofi, Novo Nordisk, obesity
US Big Pharma: What To Watch For In Q4 Results
Yahoo/Benzinga
Mon, 01/25/16 - 10:20 pm
Tags:
earnings, Eli Lilly, JNJ, Bristol-Myers Squibb, AbbVie, Pfizer, Merck
Eli Lilly’s 4Q15 Revenue Estimates: Expect Growth!
Yahoo/Market Realist
Fri, 01/22/16 - 02:41 pm
Tags:
Eli Lilly, earnings
BMS, Lilly, Sanofi and Novartis top Big Pharma's growth fortunes for next decade: Analysts
Fierce Pharma
Wed, 01/20/16 - 09:33 pm
Tags:
Eli Lilly, Sanofi, Bristol-Myers Squibb, Novartis
How Big a Threat is Eli Lilly to Gilead Sciences?
Bidness, ETC
Wed, 01/20/16 - 08:40 am
Tags:
Eli Lilly, Gilead Sciences, baricitinib, JAK inhibitors
Incyte's stock surges after receiving milestone payment from Eli Lilly
Marketwatch
Tue, 01/19/16 - 08:30 am
Tags:
Incyte, Eli Lilly, baricitinib
China’s diabetes boom promises $23 billion pot for drug makers
Marketwatch
Fri, 01/15/16 - 02:30 pm
Tags:
China, diabetes, Novo Nordisk, Sanofi, Eli Lilly, Zhejiang Hisun Pharma
[video]Lilly CEO: Working Our Way Back From Four Lost Patents
Bloomberg
Wed, 01/13/16 - 04:07 pm
Tags:
Eli Lilly, Pharma CEOs, patents, John Lechleiter
5 Biotech Predictions for 2016
Motley Fool
Sat, 01/9/16 - 10:50 am
Tags:
biotech, GW Pharma, Medical Marijuana, Big Pharma, Alzheimer's disease, CAR-T, Portola Pharmaceuticals, Eli Lilly, Biogen, Axovant Sciences
3 Potential Blockbuster Drugs Launching in 2016
Investors.com
Wed, 01/6/16 - 10:57 am
Tags:
Merck, hepatitis C, elbasvir/grazoprevir, Gilead Sciences, sofosbuvir/velpatasvir, Eli Lilly, psoriasis, ixekizumab

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.